Disc Medicine holder to sell 513 shares, ~$40K
A Rule 144 notice reports Atlas Venture Fund XII’s planned resale of 513 Disc Medicine common shares originally acquired in a 2020 private placement.
Rhea-AI Filing Summary
Disc Medicine, Inc. (IRON) received a notice under Rule 144 for a proposed resale of 513 shares of Common Stock by Atlas Venture Fund XII through Merrill Lynch. The shares were originally acquired from the issuer in a private placement on May 1, 2020 for cash, and the filing lists 38,392,844 shares outstanding as of September 2, 2026.
Positive
- None.
Negative
- None.
Key Figures
Shares to be sold: 513 shares
Aggregate market value of shares to be sold: $40,357.71
Shares outstanding: 38,392,844 shares
+2 more
5 metrics
Shares to be sold
513 shares
Common Stock proposed for resale under Rule 144 by Atlas Venture Fund XII
Aggregate market value of shares to be sold
$40,357.71
Market value of the 513 shares proposed to be sold
Shares outstanding
38,392,844 shares
Common Stock outstanding as of September 2, 2026
Acquisition date of shares
May 1, 2020
Date the 513 shares were acquired in a private placement for cash
Date of notice
September 2, 2026
Date of the Form 144 notice signed by Ommer Chohan
Key Terms
Rule 144, Private Placement, Aggregate Market Value, Number of Shares or Other Units Outstanding
4 terms
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Private Placement financial
"Common Stock | 05/01/2020 | Private Placement | Issuer"
A private placement is a sale of securities directly to a selected group of investors, typically institutions or accredited investors, instead of through a public offering. It lets a company raise money faster and with fewer regulatory steps; for existing shareholders it matters because the newly issued shares, often sold at a discount, increase the share count and can dilute their ownership.
Aggregate Market Value financial
"Common Stock | Merrill Lynch... | 513 | 40357.71 | 38392844"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.
FAQ
What does the Form 144 filing disclose for Disc Medicine, Inc. (IRON)?
It discloses a proposed Rule 144 resale of 513 shares of Common Stock of Disc Medicine, Inc. by Atlas Venture Fund XII, with Merrill Lynch as broker, relating to shares acquired in a May 1, 2020 private placement.
Who is the selling security holder in this Disc Medicine (IRON) Form 144?
The selling security holder is Atlas Venture Fund XII, for whose account the 513 shares of Disc Medicine, Inc. Common Stock are to be sold pursuant to Rule 144.
Which broker and exchange are involved in the IRON Form 144 resale?
The proposed sale of 513 Disc Medicine, Inc. shares is listed with Merrill Lynch as broker, and the Common Stock is noted as traded on Nasdaq.
AI-generated analysis. How Rhea-AI works. Not financial advice.
